Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 14:14:623-632.
doi: 10.2147/CCID.S315846. eCollection 2021.

The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment Approach

Brigitte Dreno  1 , Jean Michel Amici  2 , Ann Laure Demessant-Flavigny  3 , Charlotte Wright  4 , Charles Taieb  5 , Seemal R Desai  6 , Andrew Alexis  7
Affiliations
Review

The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment Approach

Brigitte Dreno et al. Clin Cosmet Investig Dermatol. .

Abstract

Skin conditions such as acne, atopic dermatitis, skin toxicity from oncology treatment, and scars are among the most common health conditions and negatively impact quality of life (QoL). Yet the physician perception of this impact often varies greatly from the patient perception. This is important because patient illness perception is closely linked with seeking help and treatment adherence behaviors. The objective of this review is to better understand the impact of these four highly prevalent skin conditions on QoL including their health-related economic factors to improve treatment outcomes. The literature search included literature published on QoL with acne, atopic dermatitis, scars (from any cause) and skin toxicities on PubMed between 2015 and 2020. We found that patients with skin conditions have a much higher frequency of altered QoL and psychological distress than those without. Also, skin conditions negatively impact self-image and can cause feelings of isolation, loneliness, lower self-esteem, and lower body satisfaction. Additionally, physical discomfort adds to the psychological distress. These physical and psychological impacts are an enormous financial burden on patients, their families and society. We found evidence that holistic treatment including treating the skin condition itself, providing wider peer and psychological support as well as shared decision-making, therapeutic patient education and dermatologist involvement improves outcomes. Holistic history-taking, checklists, or the use of more formal QoL scoring tools can be incorporated into routine consultations to better assess patient well-being and provide clinicians with important information for adapting treatment to individual patient requirements. In conclusion, this review highlights the overall impact of skin conditions (including psychological and QoL impacts) and the importance of providing holistic care to optimize treatment outcomes. A comprehensive QoL screening tool would be useful to help provide patient-centered treatment.

Keywords: acne; atopic dermatitis; burns; quality of life; scars; skin toxicities.

PubMed Disclaimer

Conflict of interest statement

AL Demessant-Flavigny is an employee of L'Oreal, La Roche-Posay, France. Mrs Charlotte Wright reports personal fees for manuscript preparation from La Roche-Posay, during the conduct of the study. Dr. Seemal R. Desai reports personal fees from L’Oreal, outside the submitted work. Dr. Andrew Alexis reports grants and personal fees from Leo, Novartis, Almiral, during the conduct of the study; grants and personal fees from Leo, Novartis, Almirall, Bristol Myers Squibb, Amgen, Menlo, Galderma, Valeant/Bausch Health, Cara, Arcutis, Pfizer, SANOFI-Regeneron, Dermavant, Unilever, Beiersdorf, L’Oreal, Scientis, UCB, Foamix, Cassiopea, Janssen, Allergan, AbbVie, and Sol-Gel, outside the submitted work. The authors report no other conflicts of interest in this work.

References

    1. Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–1534. doi:10.1038/jid.2013.446 - DOI - PubMed
    1. Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol. 2017;153(5):406–412. doi:10.1001/jamadermatol.2016.5538 - DOI - PMC - PubMed
    1. Dreno B, Poli F. Epidemiology of acne. Dermatology. 2003;206(1):7–10. doi:10.1159/000067817 - DOI - PubMed
    1. Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172(Suppl 1):3–12. doi:10.1111/bjd.13462 - DOI - PubMed
    1. Kowalska-Olędzka E, Czarnecka M, Baran A. Epidemiology of atopic dermatitis in Europe. J Drug Assess. 2019;8(1):126–128. doi:10.1080/21556660.2019.1619570 - DOI - PMC - PubMed

LinkOut - more resources